| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Daniela Poli | |
| Emilia Antonucci | |||
| P2860 | cites work | Changes in hemodynamics and left ventricular structure after menopause. | Q53976036 |
| Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013). | Q55058346 | ||
| Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation | Q56620375 | ||
| Metabolic Syndrome Compared With Type 2 Diabetes Mellitus as a Risk Factor for Stroke | Q57505758 | ||
| Stroke risk in atrial fibrillation patients on warfarin | Q62059835 | ||
| Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators | Q67716321 | ||
| Plasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation | Q70017666 | ||
| Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin | Q71401392 | ||
| Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials | Q72030226 | ||
| Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications | Q72566134 | ||
| Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography | Q74429767 | ||
| Physical activity and stroke incidence: the Harvard Alumni Health Study | Q77359003 | ||
| Exercise type and intensity in relation to coronary heart disease in men | Q78395167 | ||
| Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study | Q78946863 | ||
| Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation | Q80579406 | ||
| Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study) | Q80820976 | ||
| Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study | Q82780404 | ||
| Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA) | Q84985096 | ||
| Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism | Q86642316 | ||
| Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. | Q51462051 | ||
| Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. | Q51672320 | ||
| Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. | Q51768133 | ||
| Gender differences and quality of life in atrial fibrillation: the mediating role of depression. | Q51774777 | ||
| Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. | Q51973358 | ||
| Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi. | Q52229885 | ||
| Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). | Q53123407 | ||
| Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. | Q53358007 | ||
| Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association | Q22306361 | ||
| Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation | Q28175492 | ||
| New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome | Q28183679 | ||
| A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin | Q28195787 | ||
| Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial | Q28196294 | ||
| Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation | Q28201331 | ||
| Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q28213401 | ||
| Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial | Q28219363 | ||
| Outcome of heart failure with preserved ejection fraction in a population-based study | Q28252947 | ||
| Dabigatran versus warfarin in patients with atrial fibrillation | Q28256895 | ||
| Hypertension in adults across the age spectrum: current outcomes and control in the community | Q28263835 | ||
| Epidemiology of atrial fibrillation: European perspective | Q28315439 | ||
| Validation of Clinical Classification Schemes for Predicting Stroke | Q29028208 | ||
| Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study | Q29614197 | ||
| 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association | Q29614695 | ||
| Rivaroxaban versus warfarin in nonvalvular atrial fibrillation | Q29614696 | ||
| Apixaban versus warfarin in patients with atrial fibrillation | Q29617563 | ||
| Edoxaban versus warfarin in patients with atrial fibrillation | Q29620669 | ||
| Prospective study of body mass index and risk of stroke in apparently healthy women. | Q30350577 | ||
| European ancestry as a risk factor for atrial fibrillation in African Americans | Q30429712 | ||
| Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study | Q33224413 | ||
| Hormone therapy and cardiovascular disease: a systematic review and meta-analysis | Q33231108 | ||
| Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data | Q33320002 | ||
| Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators | Q33863941 | ||
| Alcohol consumption and mortality: modelling risks for men and women at different ages | Q33895056 | ||
| The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. | Q33984662 | ||
| Which method of left atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation? | Q34001018 | ||
| Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study | Q34117950 | ||
| A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice | Q34146593 | ||
| Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association | Q34153132 | ||
| A comparison of rate control and rhythm control in patients with atrial fibrillation | Q34162727 | ||
| Impact of heart failure with normal ejection fraction on the occurrence of ischaemic stroke in patients with atrial fibrillation | Q44414540 | ||
| Smoking cessation and decreased risk of stroke in women | Q44764740 | ||
| Impact of atrial fibrillation on the risk of death: the Framingham Heart Study | Q45222306 | ||
| Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation | Q46142380 | ||
| Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population | Q46537848 | ||
| Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine | Q46716825 | ||
| Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension | Q46765321 | ||
| Hormone replacement therapy and adverse outcomes in women with atrial fibrillation: an analysis from the atrial fibrillation follow-up investigation of rhythm management trial | Q46783707 | ||
| Sex differences in management and outcome after stroke: a Swedish national perspective | Q47766339 | ||
| Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. | Q47790299 | ||
| Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with nonrheumatic atrial fibrillation. European Atrial Fibrillation Trial (EAFT) Study Group. | Q49226979 | ||
| Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. | Q50351428 | ||
| 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. | Q51032065 | ||
| Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials. | Q51116249 | ||
| Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. | Q51180097 | ||
| ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents | Q34180417 | ||
| Adherence to a Mediterranean diet and survival in a Greek population | Q34208988 | ||
| A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study | Q34225539 | ||
| The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). | Q34374016 | ||
| 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society | Q34412804 | ||
| Epidemiology and clinical course of heart failure with preserved ejection fraction | Q34413027 | ||
| Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands | Q34476110 | ||
| Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | Q34540479 | ||
| Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study | Q34576849 | ||
| Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited | Q34919089 | ||
| Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation | Q35003773 | ||
| Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging | Q35054472 | ||
| Body mass index and risk of stroke among Chinese men and women | Q35212290 | ||
| Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752573 | ||
| Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study | Q36001150 | ||
| Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study | Q36255692 | ||
| Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation | Q37073803 | ||
| Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study | Q37179191 | ||
| Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials | Q37292868 | ||
| Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute | Q37417065 | ||
| Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. | Q37477914 | ||
| The link between atrial fibrillation and stroke in women | Q37879680 | ||
| New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation | Q38068593 | ||
| Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis | Q38196305 | ||
| Bridging the gender gap in atrial fibrillation | Q38317687 | ||
| Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients | Q38417285 | ||
| Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation | Q39364345 | ||
| Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population | Q39854204 | ||
| Cryptogenic stroke and underlying atrial fibrillation | Q40202915 | ||
| Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease | Q41814149 | ||
| Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort | Q42850914 | ||
| Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | Q42923039 | ||
| Sex differences in presentation, severity, and management of stroke in a population-based study | Q43150920 | ||
| Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). | Q43630565 | ||
| Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program | Q43722328 | ||
| A clinical trial of estrogen-replacement therapy after ischemic stroke | Q43779426 | ||
| Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). | Q43875329 | ||
| Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study | Q44104897 | ||
| Gender-related differences in catheter ablation of atrial fibrillation. | Q44136024 | ||
| Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study | Q44234203 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atrial fibrillation | Q815819 |
| P304 | page(s) | 605-14 | |
| P577 | publication date | 2015-06-11 | |
| P1433 | published in | International Journal of Women's Health | Q6051629 |
| P1476 | title | Epidemiology, diagnosis, and management of atrial fibrillation in women | |
| P478 | volume | 7 |
| Q41686261 | Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times. |
| Q30743765 | Cardiovascular Disease in Women: Clinical Perspectives |
| Q51763998 | Changes in stroke risk by freedom-from-stroke time in simulated populations with atrial fibrillation: Freedom-from-event effect when event itself is a risk factor. |
| Q37704200 | Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry |
| Q55482598 | Recent Trends in Oral Anticoagulant Use and Post-Discharge Complications Among Atrial Fibrillation Patients with Acute Myocardial Infarction. |
| Q38953655 | Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice |
| Q93024187 | Sex-differences in post-discharge outcomes among patients hospitalized for atrial fibrillation |
| Q33880742 | Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy |
Search more.